New Consumer Survey Discovers Many Misconceptions About Heart Health

More than 100 million Americans suffer from chronic conditions, like heart disease and diabetes, according to the National Health Council. As the leading cause of death in the United States, heart disease has spurred numerous initiatives, like the Centers for Disease Control (CDC) and Center for Medicare and Medicaid Services (CMS) creating the Million Hearts 2022 campaign to reduce the number of heart attacks by the year 2022.

Despite many great efforts aimed at spreading awareness and improving the state of heart health in the U.S., our recent consumer survey found that 71 percent of Americans incorrectly selected drug use, cancer, gun violence, vehicular accidents or other factors as the leading killers of Americans. Why the disconnect? The answer may be fear.

We found that 37 percent of people have avoided seeing a doctor over the fear of diagnosis, and the top dread of those who do see a doctor (30 percent) regarding cardiac care is misdiagnosis or missed diagnosis. These concerns are not unreasonable. However, if you are at risk of heart disease, the best course of action is to talk to your physician to address any issues before they get worse.

Below are suggested questions that the American Heart Association recommends you ask your physician:

  • What are my risk factors for heart disease?
  • What are the warning signs of heart disease and stroke?
  • Do I need to lose or gain weight to improve my health?

If you are at risk for heart disease, your doctor may suggest things like weight loss or gain, more physical activity, a healthy diet, getting more sleep or a consultation with a specialist.

Remember, your health is your own. The more you know and the more you communicate your concerns with a doctor, the better your chances of having a heart-healthy future.

To read more about heart disease, click here. If you’re interested in learning more about HeartFlow and the HeartFlow Analysis, click here.

56795852 v1

© 2020 HeartFlow, Inc. HeartFlow and the HeartFlow logo are among trademarks of HeartFlow, Inc. February 2019.

The HeartFlow Analysis is a personalized cardiac test indicated for use in clinically stable symptomatic patients with coronary artery disease. The information provided by the HeartFlow Analysis is intended to be used in conjunction with the patient’s clinical history, symptoms and other diagnostic tests, as well as the clinician’s professional judgment. Patient symptoms must be documented in the patient’s medical record. While no diagnostic test is perfect, the HeartFlow Analysis has demonstrated higher diagnostic performance compared to other non-invasive cardiac tests1. If you are a patient and suspect this test may be right for you, please speak with your doctor.

1. Nørgaard, et al. J Am Coll Cardiol. 2014; Driessen, et al. J Am Coll Cardiol. 2018.